The chromatin-remodeling enzyme BRG1 promotes colon cancer progression via positive regulation of WNT3A

In this study, we aimed to elucidate the clinical significance and underlying mechanisms of BRG1 in colon cancer. In the clinical analysis, overexpression of BRG1 correlates with colon cancer progression in two cohorts (n = 191 and n = 75). Kaplan-Meier survival analysis revealed that BRG1 is a prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Shengtao, Jiang, Tao, Ye, Ling, Han, Zhongbo, Liu, Yuan, Liu, Chenchen, Yuan, Chenwei, Zhao, Senlin, Chen, Jian, Wang, Jingtao, Tang, Huamei, Lu, Su, Yang, Liguang, Wang, Xiaoliang, Yan, Dongwang, Peng, Zhihai, Fan, Junwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349896/
https://www.ncbi.nlm.nih.gov/pubmed/27852072
http://dx.doi.org/10.18632/oncotarget.13326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349896/
https://www.ncbi.nlm.nih.gov/pubmed/27852072
http://dx.doi.org/10.18632/oncotarget.13326

Ejemplares similares